(In the Media) “Study group for the suitable drug information” recommended pharmaceutical industry (the Nikkei Medical, the July 2016 edition)
date : 7/1/2016
An article featuring a “Round-table discussion among those with ‘Study group for the suitable drug information’ recommended pharmaceutical industry.’ in which Toshio Miyata, HGPI Board Member participated, appeared in the July 2016 edition of the Nikkei Medical.
This study group is organized by Nikkei Medical and the member are 5 are doctors. They take more regulation of providing drug information seriously.
In the last four meetings, they were talking about desirable drug information. And this time, they recommended the suitable drug information for the pharmaceutical industry.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
-
2026-08-14
[Registration Open] (Webinar) The 144th HGPI Seminar “Visualizing Hidden Caregiving and Building the Support of the Future – Diversifying Family Structures and the Potential for Tailored Support”(September 15, 2026)
-
2026-08-18
[Discussion Points] Obesity Control as a Challenge for Society: Perspectives from Local Governments and Employees’ Insurance Providers for the Advancement of Policies for Obesity and Obesity Disease (July 31, 2026)
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: October 1, 2026)



